News

A statement from LaVarne A. Burton, CEO and president of AKF, on the American Heart Association's advisory defining cardiovascular-kidney-metabolic syndrom...

AKF announces sponsorship from Novartis Pharmaceuticals Corporation for education and awareness campaigns for two rare kidney diseases: complement 3 glomerulopa...

AKF today expressed its appreciation for Amgen's participation in the 2022 class of its Corporate Membership Program as a Champion-level member.

AKF will present its poster "Barriers to genetic testing for determining cause of kidney disease among healthcare providers" at the American Society o...

Campaign resources will include a video series and information on genetic counseling and materials for health care professionals.

Prevention and management campaign will feature new resources to help explain seriousness of kidney disease and how to help slow or stop its progression

As a part of its Unknown Causes of Kidney Disease (UCKD) Project, AKF surveyed health care providers to understand opportunities and barriers in diagnosing chro...

March is Kidney Month, and the American Kidney Fund (AKF) is inviting members of the kidney community to join the celebration by sharing their "kidney mome...